{"id":47415,"date":"2022-08-17T23:01:37","date_gmt":"2022-08-17T21:01:37","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\/"},"modified":"2022-08-17T23:01:37","modified_gmt":"2022-08-17T21:01:37","slug":"senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\/","title":{"rendered":"Senseonics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase"},"content":{"rendered":"
\n

GERMANTOWN, Md.–(BUSINESS WIRE)–Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to present at the upcoming Inaugural Gilmartin Group Emerging Showcase, taking place virtually. Management is scheduled to present on Wednesday, August 31, 2022 at 3:00pm ET.\n<\/p>\n

<\/a><\/p>\n

\nInterested parties can access a live and recorded webcast presentation directly by following this link<\/a>. An archived webcast of the presentation will be available on the \u201cInvestors\u201d section of the company\u2019s website at www.senseonics.com<\/a>.\n<\/p>\n

\nThose parties interested in registering for the Inaugural Gilmartin Group Emerging Growth Company Showcase may do so by following this link<\/a>.\n<\/p>\n

\nAbout Senseonics<\/b>\n<\/p>\n

\nSenseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics’ CGM systems, Eversense\u00ae<\/sup>, Eversense\u00ae<\/sup> XL and Eversense\u00ae E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user’s smartphone.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nSenseonics Investor Contact<\/b>
Philip Taylor
\n
Investor Relations
\n
415-937-5406
\n
investors@senseonics.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

GERMANTOWN, Md.–(BUSINESS WIRE)–Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to present at the upcoming Inaugural Gilmartin Group Emerging Showcase, taking place virtually. Management is scheduled to present on Wednesday, August 31, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47415","6":"format-standard","7":"category-industry"},"yoast_head":"\nSenseonics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Senseonics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"GERMANTOWN, Md.–(BUSINESS WIRE)–Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to present at the upcoming Inaugural Gilmartin Group Emerging Showcase, taking place virtually. Management is scheduled to present on Wednesday, August 31, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-17T21:01:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220817005639\/en\/672068\/21\/SENS_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Senseonics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase\",\"datePublished\":\"2022-08-17T21:01:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\\\/\"},\"wordCount\":224,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220817005639\\\/en\\\/672068\\\/21\\\/SENS_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\\\/\",\"name\":\"Senseonics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220817005639\\\/en\\\/672068\\\/21\\\/SENS_logo.jpg\",\"datePublished\":\"2022-08-17T21:01:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220817005639\\\/en\\\/672068\\\/21\\\/SENS_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220817005639\\\/en\\\/672068\\\/21\\\/SENS_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Senseonics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Senseonics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\/","og_locale":"en_US","og_type":"article","og_title":"Senseonics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase - Pharma Trend","og_description":"GERMANTOWN, Md.–(BUSINESS WIRE)–Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to present at the upcoming Inaugural Gilmartin Group Emerging Showcase, taking place virtually. Management is scheduled to present on Wednesday, August 31, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-17T21:01:37+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220817005639\/en\/672068\/21\/SENS_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Senseonics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase","datePublished":"2022-08-17T21:01:37+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\/"},"wordCount":224,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220817005639\/en\/672068\/21\/SENS_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\/","url":"https:\/\/pharma-trend.com\/en\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\/","name":"Senseonics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220817005639\/en\/672068\/21\/SENS_logo.jpg","datePublished":"2022-08-17T21:01:37+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220817005639\/en\/672068\/21\/SENS_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220817005639\/en\/672068\/21\/SENS_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/senseonics-to-present-at-the-inaugural-gilmartin-group-emerging-growth-company-showcase\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Senseonics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47415","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47415"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47415\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47415"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47415"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47415"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}